PiCCO在严重腹腔感染患者治疗中的应用价值及预后影响研究

目的:探讨PiCCO在严重腹腔感染患者治疗中的应用价值及预后影响。方法:选择2017-02-2019-02期间严重腹腔感染患者88例分为对照组和观察组,每组44例。对照组给予传统监测方法,观察组利用PiCCO监测指导治疗,1个月后对患者效果进行评估,比较2组患者包括脓毒性休克、院内感染及术后吻合口瘘等并发症的发生率、中心静脉压(CVP)、尿量及平均动脉压(MAP)、血乳酸(LA)及氧合指数(PO2/FiO2)水平。结果:观察组治疗后1个月并发症总发生率低于对照组(P<0.05);观察组治疗后1个月患者中心静脉压(CVP)低于对照组(P<0.05);尿量、平均动脉压(MAP)均高于对照组(P<0.05);2组治疗过程中血乳酸(LA)及氧合指数(PO2/FiO2)水平监测均差异无统计学意义(P>0.05)。结论:PiCCO能改善严重腹腔感染患者自身指标,降低并发症发生率,有助于帮助患者尽快康复,值得推广应用。

The application value and prognosis of PiCCO in the treatment of patients with severe abdominal infection

Objective: To investigate the application value and prognosis of PiCCO in the treatment of patients with severe abdominal infection. Method: Eighty-eight patients with severe abdominal infection from February 2017 to February 2019 were enrolled in the control group and the observation group, with 44 patients in each group. The control group was given traditional monitoring methods. The observation group used PiCCO monitoring to guide the treatment. The patient’s effect was evaluated 1 month later. The incidence of complications including septic shock, nosocomial infection and postoperative anastomotic leakage was compared between the two groups. Central venous pressure(CVP), urine volume and mean arterial pressure(MAP), blood lactate(LA) and oxygenation index(PO2/FiO2) levels were compared too. Result: The total incidence of complications in the observation group was lower than that in the control group(P<0.05). The CVP was lower in the observation group than that in the control group(P<0.05). The MAP was higher than that of the control group(P<0.05). There was no statistical significance in the LA and PO2/FiO2 levels during the treatment(P>0.05). Conclusion: Picco can improve the self-indicators of patients with severe abdominal infection, reduce the incidence of complications, and help patients recover as soon as possible. It is worthy of popularization and application.